Detection of antibodies to infectious agents such as the SARS-CoV-2 virus that causes COVID-19 is routinely performed using the enzyme-linked immunosorbent assay (ELISA). Numerous serological test kits for COVID-19 have been developed and received emergency use authorization (EUA) from regulatory agencies in the past few months. Many of these test kits utilize ELISA assays to identify the presence of antibodies to the SARS-CoV-2 virus in blood samples.
Corning is an industry leader in the breadth of high quality, high-performance ELISA 1 x 8 strips and microplates available to support laboratory testing workflows. These ELISA products can be used as components in a wide range of testing workflows. Surface chemistries are also available for ELISA workflows requiring covalent immobilization to sulfhydryl groups or carbohydrate moieties.
ELISA strips and microplates are available in clear, black, or white polystyrene with a variety of different surface chemistries to suit multiple assay formats. In addition, Corning has expanded manufacturing capacity of all ELISA products to ensure global availability of these critical components in diagnostic workflows.